GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.800
+0.110 (4.09%)
At close: Jun 26, 2026, 4:00 PM EDT
2.780
-0.020 (-0.71%)
After-hours: Jun 26, 2026, 7:40 PM EDT

Company Description

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.

In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.

The company was founded in 2011 and is headquartered in Santa Monica, California.

GoodRx Holdings, Inc.
GoodRx Holdings logo
Country United States
Founded 2011
IPO Date Sep 23, 2020
Industry Health Information Services
Sector Healthcare
Employees 697
CEO Wendy Barnes

Contact Details

Address:
2701 Olympic Boulevard
Santa Monica, California 90404
United States
Phone 855 268 2822
Website goodrx.com

Stock Details

Ticker Symbol GDRX
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $33.00
CIK Code 0001809519
CUSIP Number 38246G108
ISIN Number US38246G1085
Employer ID 47-5104396
SIC Code 7374

Key Executives

Name Position
Wendy Barnes President, Chief Executive Officer and Director
Douglas Joseph Hirsch Co-founder and Director
Christopher A. McGinnis Chief Financial Officer and Treasurer

Latest SEC Filings

Date Type Title
Jun 18, 2026 8-K Current Report
May 13, 2026 144 Filing
May 6, 2026 10-Q Quarterly Report
May 6, 2026 8-K Current Report
Apr 29, 2026 ARS Filing
Apr 29, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2026 DEF 14A Other definitive proxy statements
Apr 24, 2026 8-K Current Report
Apr 3, 2026 8-K Current Report
Mar 27, 2026 8-K Current Report